News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Analysts Claim "Smoking Gun" On Alleged Mindray Medical Fraud


1/20/2014 6:58:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Analysts at short-seller Ottoman Bay Research, which have long held that Mindray Medical (NYSE:MR) management has misled investors, claim that they've found the so-called "smoking gun" that proves their accusations. Ottoman Bay said that it gathered "in-country" regulatory filings dating back as far as 2010 from all the local registries for each of Mindray's operating subsidiaries, claiming that the documents prove that China-based Mindray is not what it seems. The analysts claimed that "MR's international business ... has been hiding significant operating and net profit losses in its subsidiaries for years," and that "the MR story also comes with misrepresented financials, multiple auditor resignations, hidden losses in subsidiaries and governance abuses."

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at Seeking Alpha
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES